The ubiquitin proteasome system (UPS) controls the cellular concentrations of regulatory proteins, degrades aberrant or misfolded polypeptides, and produces peptides as part of the adaptive immune response[@R1]. Most proteins are targeted to the proteasome by the covalent attachment of many copies of the small protein ubiquitin[@R2]. This modification is recognized directly by the proteasome[@R3],[@R4] which then degrades its substrates by running sequentially along the substrates\' polypeptide chain[@R5]. Many UPS substrates, such as cyclins, cyclin-dependent kinase (CDK) inhibitors, transcription regulators (*e.g.*, IκBα), and transcription factors, are parts of multimeric complexes before degradation[@R1]. In some of these cases, the proteasome degrades specifically only one of the subunits to create a remodeled complex with a new composition and function. This remodeling activity of the proteasome was first demonstrated through the observation of subunit specificity in the degradation of tetrameric βgal substrates *in vitro*[@R6] and *in vivo*[@R7]. Two well-known physiological examples of subunit-specific degradation are the proteolysis of cyclins from their complex with CDK[@R8] and the proteolysis of the CDK inhibitor Sic1 while bound to the cyclin / CDK complex[@R9]. Until now, the specificity of degradation by the proteasome has been assumed to result directly from the specificity of the ubiquitination reaction. In other words, the protease has been thought to begin to degrade its substrate at point of the ubiquitin modification and, therefore, to degrade only the ubiquitinated subunit.

However, protein ubiquitination, or protein binding to the proteasome, are not sufficient for effective degradation. For example, the ubiquitinated Cdc34[@R9]-[@R11] and proteasome-bound Rad23[@R10],[@R12],[@R13] are stable proteins. The reason for this is probably that efficient proteasome-mediated proteolysis requires the presence of a second component of the degradation signal in the form of an unstructured initiation site in the substrate[@R14]. The ubiquitin tag allows the proteasome to bind target proteins[@R3],[@R4], and the unstructured region serves as the initiation site where the proteasome begins to degrade the substrate[@R14]. We now ask whether the two components of the targeting signal could work together when separated onto two different polypeptides chains in a complex. The existence of a *trans*-targeting mechanism of this type would require a new explanation for the observed subunit specificity of the proteasome.

We find that a substrate protein that lacks a ubiquitin modification can be targeted for rapid degradation when it associates with a ubiquitinated partner protein that serves as a proteasome adaptor. While the adaptor localizes the substrate onto the proteasome, the adaptor itself can remain stable and act catalytically. Insertion of an initiation site into the ubiquitinated adaptor leads to the degradation of the adaptor and the relative stabilization of the binding partner. Therefore, we propose that the subunit specificity of the proteasome results from the selection of the degradation initiation site and is not determined primarily by the location of the ubiquitin modification.

Results {#S1}
=======

Targeting and degrading subunits of a protein complex {#S2}
-----------------------------------------------------

To investigate the degradation of protein complexes by the proteasome, we constructed a series of UPS substrates from the ribonuclease barnase and its inhibitor barstar[@R15] ([Fig. 1a](#F1){ref-type="fig"}). The two proteins bind each other with a dissociation constant of ∼10^−9^ M ([@R16]) to form a well-characterized complex. First, we targeted proteins to degradation in reticulocyte lysate using the N-end rule degron developed and characterized previously (*e.g.*, [@R17]-[@R19]). The N-degron contains both ubiquitination and initiation sites[@R14] and induces the efficient degradation of proteins[@R19]. We fused the N-degron to the N terminus of barstar through a DHFR linker domain to make N-degron-DHFR-barstar ([Fig. 1b](#F1){ref-type="fig"}). When we incubated the hybrid protein in reticulocyte lysate, the ubiquitin moiety at its N terminus was cleaved rapidly, and the remainder was ubiquitinated on Lys residues downstream in the degron ([Supplementary Fig. 1](#SD1){ref-type="supplementary-material"} online). The ubiquitinated protein was then degraded by the proteasome ([Fig. 1c](#F1){ref-type="fig"}). As expected for protein degradation by the UPS, proteolysis was inhibited by both the depletion of ATP and the addition of a lysine-less ubiquitin mutant, which prevents polyubiquitination ([Fig. 1c](#F1){ref-type="fig"}). The proteasome inhibitor MG132 (**1**) also prevented degradation and led to the accumulation of the ubiquitinated substrate ([Fig. 1c](#F1){ref-type="fig"}). Ubiquitination occurred in the linker region between the N-terminal ubiquitin and the DHFR-barstar fusion because deletion of a large part of the linker (indicated by the square bracket in [Fig. 1b](#F1){ref-type="fig"}) prevented ubiquitination and degradation of the protein ([Fig. 1c](#F1){ref-type="fig"}).

Attaching the N-end rule degron next to the N terminus of barnase ([Fig. 1b](#F1){ref-type="fig"}) led to rapid ubiquitination and degradation of barnase in rabbit reticulocyte lysate, even when barnase was bound to barstar[@R5] ([Fig. 2a](#F2){ref-type="fig"}). Thus, the proteasome was able to extract its substrate from the complex as expected[@R5]-[@R9]. Next, we removed the N-degron from barnase and transferred it back to the N terminus of barstar through the DHFR linker (to make N-degron-DHFR-barstar; [Fig. 1b](#F1){ref-type="fig"}). As a result, the bound barnase was no longer degraded because it lacked both a ubiquitin modification and a degradation initiation site ([Fig. 2b](#F2){ref-type="fig"}). However, surprisingly, barnase was degraded again when we appended unstructured regions to its N terminus ([Fig. 2c](#F2){ref-type="fig"}). Degradation was due to the UPS because degradation depended on the presence of the N-degron on barstar ([Fig. 2d](#F2){ref-type="fig"}), and degradation was inhibited by any one of three events: ATP depletion, the addition of an excess of ubiquitin lacking Lys residues, or the proteasome inhibitor MG132 (**1**) ([Fig. 2e](#F2){ref-type="fig"}).

Barnase had to be bound to barstar containing the ubiquitination tag to be degraded. Gel filtration of the complex showed that barnase and barstar associated ([Fig. 2f](#F2){ref-type="fig"}), and displacement of the ubiquitinated barstar from barnase through the addition of an excess of unmodified barstar prevented barnase degradation ([Fig. 2g](#F2){ref-type="fig"}). Barnase containing the appended unstructured region remained stable when not bound to barstar ([Supplementary Fig. 2](#SD1){ref-type="supplementary-material"} online).

It is unlikely that barnase itself became ubiquitinated in these experiments because it contained only one Lys residue, which was buried at the center of the barstar-binding site. Some proteins become ubiquitinated at their N-terminal α-amino group[@R20], but this mechanism is unlikely to explain the degradation of the barnase subunit here. N-terminal ubiquitination usually depends on specific amino acid sequences near the N terminus[@R20], yet we found that two unrelated sequences at the N terminus of barnase (from yeast cytochrome b~2~ and *E. coli* lac repressor) led to its degradation ([Fig. 2c](#F2){ref-type="fig"}). Furthermore, barnase was not degraded when bound to barstar lacking the N-degron ([Fig. 2d](#F2){ref-type="fig"}) or to barstar in which the N-degron was inactivated by a deletion of the 24 amino acid flexible linker following the Arg residue[@R18] (data not shown). Finally, and most importantly, degradation can be reconstituted with purified components in the absence of ubiquitination machinery (see below).

Altogether, the observations described above suggest that the proteasome degrades the unmodified barnase subunit by engaging the initiation site on barnase in *trans* to the ubiquitin modification on a binding partner.

The adaptor acts catalytically and in *trans* {#S3}
---------------------------------------------

Next, we reconstituted the degradation of purified barstar and barnase protein complex by purified yeast 26S proteasome ([Fig. 3a--e](#F3){ref-type="fig"}). In these experiments, barstar was targeted to the proteasome ([Fig. 3a](#F3){ref-type="fig"}) by a tag consisting of four ubiquitin moieties fused in the same reading frame to barstar\'s N terminus[@R21],[@R22] (Ub~4~-barstar; [Fig. 3b,c](#F3){ref-type="fig"}). Barnase contained a 35 amino-acid long unstructured region at its N terminus to serve as an initiation site (USR1-barnase, where USR stands for unstructured region; [Fig. 3b,c](#F3){ref-type="fig"}). When mixed together, USR1-barnase bound to Ub~4~-barstar and was degraded by the purified proteasome ([Fig. 3d](#F3){ref-type="fig"}).

To be degraded, USR1-barnase had to be bound to Ub~4~-tagged barstar and remained stable when bound to untagged barstar ([Fig. 3d](#F3){ref-type="fig"}). USR1-barnase was degraded even when the Ub~4~-barstar adaptor was present at five times lower concentration than the USR1-barnase substrate ([Fig. 3d](#F3){ref-type="fig"}). This suggests that the adaptor was recycled and could act catalytically. Degradation of USR1-barnase was prevented when excess untagged barstar competed with Ub~4~-barstar for barnase binding. Addition of excess untagged barstar inhibited degradation rapidly when added at the beginning of the reaction or at a delay after the reaction was started ([Fig. 3e](#F3){ref-type="fig"}).

USR1-barnase also had to contain an unstructured region to be degraded ([Fig. 3f](#F3){ref-type="fig"}). Barnase lacking an unstructured region bound to Ub~4~-barstar (not shown) but remained stable ([Fig. 3f](#F3){ref-type="fig"}). These observations show that barnase is degraded after it forms a complex with ubiquitinated barstar only when it contains an initiation site for the proteasome. They suggest that a ubiquitin modification can target a protein to degradation by acting in *trans*. The ubiquitinated barstar acts as an adaptor that is recycled and used multiple times ([Fig. 3g](#F3){ref-type="fig"}).

Substrate selection through the initiation site {#S4}
-----------------------------------------------

Next we analyzed how the proteasome selects its substrate when more than one subunit contains an initiation site. In experiments in reticulocyte lysate ([Fig. 2](#F2){ref-type="fig"}), the N-degron-DHFR-barstar adaptor protein was degraded together with the barnase substrate ([Fig. 4](#F4){ref-type="fig"}) because both the ubiquitinated barstar adaptor and the barnase substrate contain degradation initiation sites. The adaptor and proteasome were present in molar excess over that of the barnase substrate: barstar was added to 0.25 μM, barnase was added to a concentration of less than 20 nM, and the concentration of the proteasome in reticulocyte lysate has been estimated to be above 1 μM ([@R23]). Stabilizing the DHFR domain against unfolding with the ligand methotrexate (**2**) protected the N-degron-DHFR barstar adaptor from degradation[@R24] but did not affect degradation of the barnase substrate ([Fig. 4](#F4){ref-type="fig"}). Thus, the stability of the adaptor did not affect its ability to target barnase for degradation when both the adaptor and the proteasome were present in molar excess over the barnase substrate ([Fig. 4](#F4){ref-type="fig"}).

We then investigated how the proteasome selects substrates within a complex using the purified degradation system. In this series of experiments, the barstar adaptor contained different spacers between the ubiquitin tag and the barstar domain, and the barnase substrate contained a 35 amino acid long unstructured initiation site derived from cytochrome *b*~2~ ([Fig. 3](#F3){ref-type="fig"}). We first used barstar adaptor at a concentration ten-times lower than that of the barnase substrate. When the barstar adaptor contained no extended unstructured regions, it remained stable and only the barnase substrate was degraded, presumably because the proteasome was unable to initiate degradation of the adaptor ([Fig. 5a](#F5){ref-type="fig"}). Introducing a long unstructured linker into the adaptor led to the adaptor\'s degradation and thus turned the adaptor it into a substrate ([Fig. 5b](#F5){ref-type="fig"}). At the same time, proteolysis of the barnase substrate was inhibited ([Fig. 5b](#F5){ref-type="fig"}). The linker in barstar did not prevent complex formation (data not shown), and the introduction of a folded domain instead of the unstructured region into the adaptor did not destabilize the barstar adaptor and did not inhibit the degradation of barnase substrate ([Fig. 5c](#F5){ref-type="fig"}). Thus, the explanation for the inverted stability of the adaptor and substrate is probably that the unstructured region in the adaptor is a better proteasome initiation site than the tail on the substrate. The adaptor is present at much lower concentrations than the substrate, therefore, the substrate is stabilized as the adaptor is depleted rapidly.

When both subunits are present at the same concentration, the proteasome also selects its substrate for degradation by the initiation site. If only the barnase substrate has an effective initiation site, either because the adaptor contains no unstructured initiation site ([Fig. 6a,b](#F6){ref-type="fig"}), or because its unstructured region has an amino acid composition that does not support effective initiation[@R25] ([Fig. 6c](#F6){ref-type="fig"}), then only the substrate is degraded. If a better initiation site is introduced into the adaptor, then the adaptor is degraded more effectively than the substrate, although both subunits are accessible to the proteasome to some extent ([Fig. 6d](#F6){ref-type="fig"}). The protease may be selecting the subunit to degrade stochastically, digesting either one or the other of the subunits in any one complex (*i.e.*, for each complex choosing either pathway 1 or 2 in [Fig. 6e](#F6){ref-type="fig"}). Alternatively, the proteasome might be able to degrade both subunits simultaneously in each complex (pathway 3 in [Fig. 6e](#F6){ref-type="fig"}). Together, these results show that both subunits in the complex are accessible to the proteasome and that the protease selects the subunit with the preferred initiation site for degradation ([Fig. 6e](#F6){ref-type="fig"}).

Discussion {#S5}
==========

We find that the two components of the proteasome targeting signal, the ubiquitination and initiation sites, can function together after being separated onto two different polypeptide chains and thus act in *trans*. A protein that itself is not ubiquitinated can be degraded efficiently if it contains an initiation site and binds to a ubiquitinated partner. The ubiquitinated subunit functions as an adaptor that localizes the complex to the proteasome, which in turn engages and unravels the subunit that contains the initiation site.

Degradation by *trans* initiation may provide a mechanism by which some proteins convert stable cellular factors into proteasome substrates by binding to both proteasome and the factor. For example, the human papillomavirus protein E7 causes uncontrolled cell growth by binding to the retinoblastoma tumor suppressor protein (Rb) and targeting it for degradation through an unresolved mechanism[@R26]. E7 itself is known to be ubiquitinated and to bind to the proteasome regulatory cap directly through its C-terminal region[@R27]. Mutations in E7 that prevent it from binding to the proteasome or to Rb also prevent E7 from targeting Rb for degradation and from transforming cells[@R26]. Thus, it is likely that E7 functions as a proteasome adaptor protein that targets Rb for degradation through the *trans*-initiation mechanism described above. Other proteasome interacting proteins such as gankyrin and Mdm2 are found to accelerate the destruction of their binding partners by the proteasome. They, too, may act as adaptors and bring their substrates\' initiation sites near the proteasome[@R28]. More recently, it was shown that the cytidine deaminase APOBEC3G can be targeted for proteasome degradation by ubiquitinated viral infectivity factor (VIF) even when APOBEC3G does not contain lysine residues, which again suggests that VIF might act as a proteasome adaptor[@R29]. Finally, some adaptor proteins such as Rad23 and Dsk2, as well as several E3 ligases, bind to both ubiquitinated proteins and the proteasome to target them for destruction, presumably by the adaptor mechanism described above[@R30]-[@R33]. Although substrates bound to this class of adaptor proteins are ubiquitinated, the ubiquitin modification is used to bind to the adaptor, which in turn binds to the proteasome[@R34].

The observation of *trans* targeting also raises an important question. The proteasome remodels some protein complexes by specifically degrading individual subunits[@R6],[@R7]. The finding that a ubiquitinated subunit can target a binding partner for degradation rules out that the location of the ubiquitination site itself determines degradation specificity. Instead, we propose that the proteasome primarily selects the subunit to degrade by choosing the degradation initiation site. In some cases, subunits may simply escape degradation because they lack any unstructured region that could serve as an initiation site. For example, ubiquitinated cyclins A and B are degraded when bound to CDKs while the CDKs remain stable[@R8]. The crystal structure of CDK2 shows it to have a compact tertiary structure devoid of disordered regions[@R35]; therefore, it lacks proteasome initiation sites. In contrast, the N-terminal region of cyclin is largely disordered and contains the ubiquitination site[@R36],[@R37]. In human cyclin A, this region corresponds to amino acids 1 through 172 ([@R35]), so we predict that these amino acids serve as the proteasome initiation site in the degradation of the cyclin A in its complex.

Not all unstructured sequences can serve as proteasome initiation sites. For example, unstructured regions have to have a certain minimum length to function effectively and may have to be within a certain distance from the ubiquitin modification[@R14]. The sequence composition of the initiation site affects subunit selection too[@R25]. Some polypeptide sequences of low compositional complexity are poor proteasome initiation sites[@R18],[@R25] and can also attenuate progression of degradation by the proteasome[@R25],[@R38].

In some cases the situation is more complicated because several subunits may contain functional initiation sites. For example, the proteasome selectively degrades CDK inhibitor from its complex with CDK and cyclin to facilitate progression through the cell cycle[@R9], even though cyclins are also proteasome substrates. CDK inhibitors such as p27 (Kip1) contain large natively unfolded segments next to the ubiquitin modification[@R39]. The situation here may be analogous to our observation that a ubiquitinated adaptor with a good initiation site is degraded rapidly so that a substrate with a less effective initiation site escapes degradation ([Figs. 5](#F5){ref-type="fig"} and [6](#F6){ref-type="fig"}). If both subunits contain similarly good initiation sites, both can be degraded ([Fig. 6](#F6){ref-type="fig"}). The proteasome may do so by selecting its substrate stochastically in individual complexes, or it may be able to degrade two substrates at the same time. Previous experiments have shown that more than one polypeptide chain can be fed through the degradation channel simultaneously[@R40] and that several substrate proteins can associate with the proteasome at the same time[@R41].

Finally, our findings also suggest a way of designing artificial adaptor proteins that can target specific proteins for proteasome degradation in the cell[@R42]. Several strategies have been explored previously to silence protein activity by artificially forcing their degradation by the proteasome. Proteins were delivered to the proteasome by three methods: fusing domains of rapidly degraded polypeptides to the target protein[@R43]-[@R46]; introducing dimerization domains into target protein and proteasome[@R47]; and conjugating short peptides containing the recognition site for a ubiquitin ligase to small molecule ligands (Protacs) that bind to target proteins and induce their ubiquitination[@R48]. Our findings suggest a strategy in which a ubiquitin fusion tag would be attached to a protein ligand. Ligand binding, either spontaneous or induced, would then target the binding partner to degradation.

In summary, we find that the two elements of the proteasome targeting signal, ubiquitin modification and initiation site, can work together even when located in *trans* on two different molecules. We propose that the location of the degradation initiation site, rather than the ubiquitin modification, determines the specificity of subunit degradation.

Methods {#S6}
=======

Proteins {#S7}
--------

Proteasome substrates are derived from two proteins that form a tight complex *in vitro*: the ribonuclease barnase and its inhibitor barstar both from *Bacillus amyloliquefaciens*. Barnase contained the mutation H102A to inactivate the ribonuclease activity and the mutations K19,62,66,108R, K39A, and K49,98M to remove ubiquitin modification sites. Barstar contained the two mutations C40,82A that abolish dimerization. Proteins were targeted for degradation using two different degrons. In the experiments performed in reticulocyte lysate, ubiquitination and degradation were induced by the N end-rule degron (N-degron)[@R17]-[@R19], which was composed of N-terminal wildtype ubiquitin followed by an arginine residue, a six amino acid linker (HGSGAW), an 18 amino acid region (residues 318-335) derived from an internal region of lac repressor protein, and a three amino acid linker (Ala-Met-Gly) ([Fig. 1b](#F1){ref-type="fig"}). In the experiments performed with purified yeast proteasome, a Ub~4~-degron was used, which was composed of four ubiquitin moieties containing the mutation G76A that were connected by their N and C termini through a six-residue linker (GSGGGG)[@R21]. The Ub~4~ tag was attached in frame to the N terminus of barstar through a short, 16 amino acid linker (Ub~4~-barstar, [Figs. 3](#F3){ref-type="fig"}, [5](#F5){ref-type="fig"}, [6](#F6){ref-type="fig"}), through *E. coli* DHFR, which is 159 amino acids long (Ub~4~-DHFR-barstar, [Figs. 5c](#F5){ref-type="fig"} and [6b](#F6){ref-type="fig"}), or through a 210 amino acid unstructured region consisting of two copies of the 1-95 residues of the mitochondrial precursor protein cytochrome *b~2~* (Ub~4~-USR2-barstar, [Fig. 5b](#F5){ref-type="fig"}). USR stands for "unstructured region". In the degradation experiments in which the barstar adaptor and barnase substrate are present in equimolar amounts ([Fig. 6](#F6){ref-type="fig"}), the Ub~4~ tag is attached to barstar also through a 102 amino acid-long linker that was composed of 66% Ser residues and described previously[@R25] (Ub~4~-USR3(Ser-rich)-barstar, [Fig. 6c](#F6){ref-type="fig"}) or through a 129 amino acid unstructured region derived from NFκB subunit p105 (in frame fusion of p105 residues 352-403 and 367-425) (Ub~4~-USR4-barstar, [Fig. 6d](#F6){ref-type="fig"}). The Ub~4~-USR4-barstar protein is more soluble than Ub~4~-USR2-barstar and therefore more suitable for the experiments in which adaptor and substrate are present in equimolar amounts because these have to be performed at higher protein concentrations. In addition, Ub~4~-USR4-barstar and Ub~4~-USR3(Ser-rich)-barstar are of similar length, making the comparison of these proteins more straightforward ([Fig. 6](#F6){ref-type="fig"}). USR4 is rich in glycine, and a part of it has previously been described as a glycine-rich region, but glycine is not as overrepresented in USR4 as serine is overrepresented in USR3. In the barnase hybrid proteins, either the N end-rule degron, or the unstructured regions that served as initiation sites, were attached to the N terminus of the ribonuclease. In the experiments performed in reticulocyte lysate, the N-terminal initiation site in the barnase was derived from residues 1-95 of mitochondrial precursor cytochrome b~2~ or from two copies of an internal region of lac repressor (residues 318-348). In either initiation site, all lysine residues were mutated to arginine or glutamine. In the experiments performed with purified yeast proteasome, the N-terminal initiation site of barnase consisted of residues 1-35 of cytochrome b~2~ (USR1). The identities of the gene constructs were confirmed by DNA sequencing.

Protein expression and purification {#S8}
-----------------------------------

Barstar and barnase constructs were overexpressed in and purified from *E. coli* using standard methodology. Details of the purification protocols are described in the [Supplementary Methods](#SD1){ref-type="supplementary-material"} online.

Yeast proteasome was from the *S. cerevisiae* strain YYS40 (*MATa rpn11∷RPN11^3FLAG^-HIS3 leu2 his3 ura3 trp1 ade2 can1 ssd1*) in which the lid subunit Rpn11 is tagged with three FLAG tags at its C terminus[@R49]. The 26S proteasome was purified using M2-agarose FLAG affinity beads (Sigma), according to the previously published protocol[@R49].

Proteasome Degradation Assays {#S9}
-----------------------------

For degradation assays in rabbit reticulocyte lysate, the lysate (Green Hectares) was depleted of ATP as described[@R19]. *In vitro* translated \[^35^S\]-methionine labeled barnase protein was added to ATP-depleted reticulocyte lysate in buffer containing 5% \[v/v\] glycerol, 5 mM MgCl~2~, 50 mM Tris/Cl \[pH 7.4\] and supplemented with 1 mM DTT, 25 μM ubiquitin or 100 μM lysine-less ubiquitin (Boston Biochem). Purified barstar or barstar fused to the N-degron was used at 0.25 μM. Reactions were first incubated at 30 °C for 30 min to allow removal of the N-terminal ubiquitin. Ubiquitination and degradation were initiated by addition of 1 mM ATP and an ATP-regeneration system (10 mM creatine phosphate, 0.1 mg/ml creatine phosphokinase). Incubation was continued at 30 °C, and equal volume samples were withdrawn at the indicated times and added to SDS-PAGE sample buffer to stop the reaction. Samples were resolved by SDS-PAGE and analyzed and quantified by electronic autoradiography (Instant Imager, Packard).

Assays with purified proteasome contained 0.25 μM 26S yeast proteasome in 5% \[v/v\] glycerol, 5 mM MgCl~2~, 50 mM Tris/Cl \[pH 7.4\], 1 mM DTT, ATP-regeneration system (1 mM ATP, 10 mM creatine phosphate, 0.1 mg/ml creatine phosphokinase). Indicated amounts of purified barstar adaptor were bound to 0.5 μM barnase proteins at 30 °C for 15 min and the complex was added to the purified proteasome to start the degradation reaction. At the indicated times, samples of equal volumes were withdrawn and added to sample buffer and analyzed by SDS-PAGE followed by immunoblotting. Barnase and barstar proteins were visualized using rabbit antibodies specific to barnase and to barstar\'s His~6~ tag (Bethyl Labs), respectively, and Alexa-680 labeled secondary antibodies. Proteins were quantified using an Odyssey infrared imaging system (LI-COR Biosciences).

Size Exclusion Chromatography {#S10}
-----------------------------

Radioactive barnase protein was allowed to bind to 0.25 μM barstar or N-degron-DHFR-barstar at 30 °C for 30 min. The barnase-barstar complex was resolved by Sephacryl S-100 high-resolution matrix (Amersham) in a 70/50 column (V~T~ = 20 ml, V~o~ = 7ml) (BioRad). 0.25 ml fractions were collected and precipitated with 10 % \[w/v\] trichloroacetic acid. The protein pellets were resolved by SDS-PAGE and quantified by electronic autoradiography (Instant Imager, Packard).

Supplementary Material {#S11}
======================
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![Proteasome substrates and N end rule degron-mediated degradation. (**a**) Structure of barnase bound to its inhibitor barstar \[PDB ID 1BRS\] and the molecular surface of this complex shown in cartoon representation using PyMol (DeLano Scientific LLC, Palo Alto, CA; [www.pymol.org](http://www.pymol.org)). (**b**) Barstar and barnase hybrid proteins. Barstar was targeted to the proteasome in reticulocyte lysate by an N end rule tag, which was composed of an N-terminal ubiquitin followed by an unstructured extension containing two lysine residues (N-degron). The N-degron was attached to the N terminus of barstar through an intervening DHFR domain. Barnase was targeted to the proteasome through an N end-rule degron in which the linker contained an additional 15 amino acids. Other barnase constructs contained N-terminal unstructured initiation sites derived from cytochrome b~2~ or lac repressor. (**c**) Proteolysis of barstar by the ubiquitin proteasome system in rabbit reticulocyte lysate. Incubation of N-degron-DHFR-barstar in reticulocyte lysate leads to its rapid degradation, which was inhibited in the absence of ATP, by addition of an excess of a ubiquitin mutant that inhibits poly-ubiquitination because it lacks all Lys residues, and by the proteasome inhibitor MG132 (**1**). Vertical lines separate radiogram images from different gels that were acquired simultaneously and set to the same exposure. Ubiquitination of substrates occurs at the lysine residues in the linker region of the N-degron, and deletion of the linker region in N-degron eliminates substrate ubiquitination as well as its degradation.](nihms77123f1){#F1}

![The proteasome degrades an unubiquitinated subunit in a heterodimeric complex. Radiolabeled barnase protein bound to its ligand barstar or to barstar containing the N-degron was degraded by the proteasome at 30 °C. (**a**) Barnase containing an N-degron and an initiation site was efficiently degraded by the proteasome when in complex with its ligand barstar. The N-degron is modified with many ubiquitin moieties, but, for simplicity, the polyubiquitin modification is indicated by four ubiquitin moieties in the schematic representation. (**b**) Barnase bound to N-degron-DHFR-barstar was not degraded by the proteasome unless (**c**) initiation sites derived from lac repressor (open circles) or cytochrome b~2~ (filled circles) were attached to barnase\'s N terminus. (**d**) Barnase proteins containing N-terminal initiation sites were not degraded when bound to barstar was not ubiquitinated because it lacked the N-degron. (**e**) Proteolysis of barnase bound to N-degron-DHFR-barstar adaptor was dependent on an active ubiquitin-proteasome system and was inhibited in the absence of ATP (filled squares) by the proteasome inhibitor MG132 (**1**) (open circles) and by the addition of excess of a ubiquitin mutant that inhibits poly-ubiquitination because it lacks all Lys residues (open squares). (**f**) Size exclusion chromatography elution profiles of \[^35^S\]-labeled barnase containing an unstructured initiation site bound to barstar or a barstar hybrid containing an N-degron. (**g**) Barnase containing an initiation site was assembled with N-degron-DHFR-barstar in the absence (filled circles) or presence (open squares) of 10-fold excess of untagged barstar and was degraded by the proteasome in rabbit reticulocyte lysate at 30 °C. Graphs show one representative dataset of at least three independent experiments.](nihms77123f2){#F2}

![*trans* initiation by the proteasome. (**a**) Coomassie blue stained SDS-PAGE gels separating 15 μg of purified yeast 26S proteasome. Proteasome subunits are labeled following published reports[@R49]. (**b**) Barstar was targeted to the proteasome by an N-terminal Ub~4~ degron composed of four ubiquitin moieties fused in frame and then through a 16-residue linker to barstar. Barnase contained a 35 amino acid N-terminal unstructured region derived from cytochrome b~2~ (USR1-barnase). (**c**) Coomassie blue stained SDS-PAGE gels separating 1 μg of indicated proteins. (**d**) 0.5 μM USR1-barnase was assembled with 1 μM (2X) or 0.1 μM (0.2X) barstar (open symbols) or Ub~4~-barstar (filled symbols), and the complex was degraded by purified yeast proteasome. The graph shows the amount of barnase remaining (quantified by Western blotting) as a function of reaction time. (**e**) 0.5 μM USR1-barnase was assembled with Ub~4~-barstar (0.2 μM; filled squares) and degraded. A 10-fold excess of untagged barstar (open symbols) was added at the beginning of (squares) or 20 min after starting the reaction (circles), as indicated by bold arrows. (**f**) Degradation required an unstructured initiation site on the barnase substrate. The proteasome did not degrade barnase that lacked an unstructured region even when bound to 1 μM (2X) or 0.1 μM (0.2X) Ub~4~-barstar. (**g**) Schematic representation of *trans* initiation. A ubiquitinated protein may act as a recycling adaptor to shuttle its binding partner to the proteasome. The sketch shows a proteasome particle capped by two PA700 regulatory particles but other forms also exist. Graphs show one representative dataset of at two (**e**) or three independent experiments.](nihms77123f3){#F3}

![Substrate selection in reticulocyte lysate. (**a-d**) \[^35^S\]-methionine labeled barnase containing an initiation site was bound to an excess of N-degron-DHFR-barstar (0.25 μM) and degraded by the proteasome in reticulocyte lysate at 30 °C in the absence (**a, b**) or presence (**c, d**) of 100 μM methotrexate (**2**). Lanes in the autoradiograms contain equal samples of the reaction at the indicated times. (**a, c**) Trace amounts of radiolabeled N-degron-DHFR-barstar were added to reactions to visualize its stability in the reaction by SDS-PAGE and autoradiography. (**b, d**) Degradation of the barnase substrate was followed in parallel by SDS-PAGE and autoradiography. (**e, f**) Quantifications of the full-length protein (indicated by arrows) and its ubiquitinated forms (indicated by square brackets) in the autoradiograms are plotted as the amounts of protein remaining as a percentage of the total protein at the beginning of the reaction. Both rapidly degrading and methotrexate (**2**)-stabilized barstar subunit (**e**) functioned similarly in targeting the associated barnase for degradation (**f**). Graphs show one representative dataset of five independent experiments.](nihms77123f4){#F4}

![Substrate selection by the purified proteasome. (**a-c**) 0.5 μM barnase containing a N-terminal initiation site (red square) was bound to 0.05 μM Ub~4~-barstar (**a**, blue circles) or 0.05 μM Ub~4~-USR2-barstar (**b**, blue circles) or 0.05 μM Ub~4~-DHFR-barstar (**c**, blue circles) and the protein complex was degraded by purified proteasome at 30 °C and analyzed by Western blotting (top). Quantifications of the gels are shown as graphs plotting the amount of barnase (red) and barstar (blue) protein remaining at different reaction times as a percentage of protein amounts at the beginning of the reaction. Note that the barnase substrate is present in 10 fold molar excess over the barstar adaptor. Graphs show one representative dataset of two (**b**) or three independent experiments.](nihms77123f5){#F5}

![Subunit-specific degradation by the proteasome. (**a-d**) 0.5 μM Barnase containing a N-terminal initiation site (red squares) was bound to 0.5 μM Ub~4~-barstar (**a**, blue circles) or 0.5 μM Ub~4~-DHFR-barstar (**b**, blue circles) or 0.5 μM Ub~4~-USR3(Ser-rich)-barstar (**c**, blue circles) or 0.5 μM Ub~4~-USR4-barstar (**d**, blue circles) and degraded by purified proteasome at 30 °C. Reactions were separated by SDS PAGE and analyzed by Western blotting. The graphs plot the amount of barnase substrate (red) and barstar adaptor (blue) protein remaining at different reaction times as a percentage of protein amounts at the beginning of the reaction. Note that the barnase substrate is present in equimolar concentration to the barstar adaptor. (**e**) Schematic representation of the substrate selection by the proteasome. Here, both subunits in the complex are accessible to the proteasome and the protease selects the subunit with the preferred initiation site for degradation (path 1 and 2). If more than one subunit contains a proteasome initiation site, multiple subunits might be degraded simultaneously (path 3) or the proteasome might switch stochastically between pathways 1 and 2. The sketch shows a proteasome particle capped by two PA700 regulatory particles. Proteasome particles may contain only one PA700 regulator or they may be activated by complexes that do not bind ubiquitin. Graphs show averages of two (**c**) or three independent experiments.](nihms77123f6){#F6}
